| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d5bb9b9a6d998b72b154ceb1895a3f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f46ae8a522d204f38a338161d0294316 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4353 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4353 |
| filingDate |
2004-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73d4325b4c765081c4a6fcb5cf7a0236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df2bab3370e2d5246a8a288ba839b12e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2202e5e4a04957f201a25b0536484df9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e3dea0e2a6a5cf1717b8bce93923926
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4328743553cf94e2431aea97a67af866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_911b96b0912a6db02b8ca4391b2fa473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f98282b61955c07735d96a1294d462a |
| publicationDate |
2006-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20060132850-A |
| titleOfInvention |
Imidazo [4,5-c] pyridine compounds and antiviral methods of treatment |
| abstract |
The present invention relates to pharmaceutical compositions for the treatment or prophylaxis of viral infections comprising as active ingredient one or more imidazo [4,5-c] pyridine prodrugs of the general formula (A). The present invention further relates to a process for the preparation and screening of the compounds of formula (A) according to the invention and their use in the treatment or prevention of viral infections.n n n <Formula A>n n n n n n n n Wherein the substituents are as described herein. |
| priorityDate |
2003-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |